CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]
Adneuris Therapeutics has granted Zhejiang Conba Pharmaceutical exclusive rights to [...]
Alto Neuroscience has raised $100 million through an underwritten registered [...]
A peer-reviewed study published in Therapeutic Innovation & Regulatory Science [...]
Gesynta Pharma has randomised half of the planned patients in [...]
PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]
Dicot Pharma has secured approximately SEK 231M (€21M) in gross [...]
Medable has launched a new support programme aimed at helping [...]
Quotient Sciences has begun a Phase 1 clinical study evaluating [...]
Patients across South Florida are set to gain greater access [...]